Suppr超能文献

相似文献

1
MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.
Cancer Biol Ther. 2014 Mar 1;15(3):329-41. doi: 10.4161/cbt.27314. Epub 2013 Dec 18.
3
Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
Clin Epigenetics. 2018 Jan 23;10:11. doi: 10.1186/s13148-018-0444-9. eCollection 2018.
4
The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
Urol Oncol. 2019 Dec;37(12):955-963. doi: 10.1016/j.urolonc.2019.08.008. Epub 2019 Oct 19.
5
Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
PLoS One. 2016 Jun 23;11(6):e0157801. doi: 10.1371/journal.pone.0157801. eCollection 2016.
6
MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
Cancer Med. 2016 Apr;5(4):656-64. doi: 10.1002/cam4.631. Epub 2016 Feb 10.
9
MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
Urol Oncol. 2020 Oct;38(10):799.e11-799.e22. doi: 10.1016/j.urolonc.2020.05.006. Epub 2020 Jun 10.

引用本文的文献

1
Liquid Biopsy as a New Tool for Diagnosis and Monitoring in Renal Cell Carcinoma.
Cancers (Basel). 2025 Apr 25;17(9):1442. doi: 10.3390/cancers17091442.
2
Non-coding transcriptome profiles in clear-cell renal cell carcinoma.
Nat Rev Urol. 2025 Mar;22(3):151-174. doi: 10.1038/s41585-024-00926-3. Epub 2024 Sep 6.
3
Exosomes as novel tools for renal cell carcinoma therapy, diagnosis, and prognosis.
Heliyon. 2024 Jun 13;10(12):e32875. doi: 10.1016/j.heliyon.2024.e32875. eCollection 2024 Jun 30.
5
Integrated analysis identifies microRNA-188-5p as a suppressor of AKT/mTOR pathway in renal cancer.
Cancer Sci. 2023 Aug;114(8):3128-3143. doi: 10.1111/cas.15832. Epub 2023 May 18.
8
Topology preserving stratification of tissue neoplasticity using Deep Neural Maps and microRNA signatures.
BMC Bioinformatics. 2022 Jan 13;23(1):38. doi: 10.1186/s12859-022-04559-4.

本文引用的文献

1
Comprehensive molecular characterization of clear cell renal cell carcinoma.
Nature. 2013 Jul 4;499(7456):43-9. doi: 10.1038/nature12222. Epub 2013 Jun 23.
2
Cancer statistics, 2013.
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
4
Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype.
Cancer Res. 2013 Jan 15;73(2):990-9. doi: 10.1158/0008-5472.CAN-12-2895. Epub 2012 Nov 29.
5
Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing.
PLoS One. 2012;7(6):e38298. doi: 10.1371/journal.pone.0038298. Epub 2012 Jun 20.
6
DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways.
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W498-504. doi: 10.1093/nar/gks494. Epub 2012 May 30.
7
Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis.
PLoS One. 2012;7(5):e35661. doi: 10.1371/journal.pone.0035661. Epub 2012 May 18.
8
MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.
Cell Cycle. 2012 Jun 1;11(11):2137-45. doi: 10.4161/cc.20598.
9
The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.
J Mol Diagn. 2012 Jul;14(4):385-92. doi: 10.1016/j.jmoldx.2012.02.003. Epub 2012 May 9.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验